Skip to main content
Drug bottle and Pill

Compare Enbrel vs. Xeljanz

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Enbrel (etanercept) and Xeljanz (tofacitinib) are both used to treat autoimmune conditions like rheumatoid arthritis and psoriatic arthritis, but they have some key differences. Enbrel is a biologic DMARD that is injected under the skin, while Xeljanz is a Janus kinase (JAK) inhibitor taken orally. Enbrel is available as brand-name and biosimilar products, whereas Xeljanz is a synthetic medication and also comes in a generic form. Enbrel works by blocking tumor necrosis factor (TNF) to reduce inflammation, while Xeljanz blocks the JAK protein to achieve the same effect. Enbrel is typically administered once a week, whereas Xeljanz is taken once or twice daily, depending on the form. Both medications can increase the risk of serious infections, but Xeljanz also has a higher risk of blood clots and heart problems. Additionally, Enbrel is approved for use in children as young as 2 years old for certain conditions, while Xeljanz is also approved for children but has more specific dosing requirements based on weight.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.